• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学的苍附导痰汤治疗多囊卵巢综合征有效成分及关键通路的研究

Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.

作者信息

Xu Wenting, Tang Mengyu, Wang Jiahui, Wang Lihong

机构信息

Department of Reproduction, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Suzhou, Jiangsu, China.

出版信息

Evid Based Complement Alternat Med. 2020 Feb 21;2020:4086864. doi: 10.1155/2020/4086864. eCollection 2020.

DOI:10.1155/2020/4086864
PMID:32148541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7057008/
Abstract

BACKGROUND

Polycystic ovary syndrome (PCOS) is the most common female endocrine disease. Cangfu Daotan Decoction (CDD) can effectively relieve the clinical symptoms of PCOS patients.

METHODS

To explore the active ingredients and related pathways of CDD for treating PCOS, a network pharmacology-based analysis was carried out. The active ingredients of CDD and their potential targets were obtained from the TCM system pharmacology analysis platform. The obtained PCOS-related genes from OMIM and GeneCards were imported to establish protein-protein interaction networks in STRING. Finally, GO analysis and significant pathway analysis were conducted with the RStudio (Bioconductor) database.

RESULTS

A total of 111 active compounds were obtained from 1433 ingredients present in the CDD, related to 118 protein targets. In addition, 736 genes were found to be closely related to PCOS, of which 44 overlapped with CDD and were thus considered therapeutically relevant. Pathway enrichment analysis identified the AGE-RAGE signalling pathway in diabetic complications, endocrine resistance, the IL-17 signalling pathway, the prolactin signalling pathway, and the HIF-1 signalling pathway. Moreover, PI3K-Akt, insulin resistance, Toll-like receptor, MAPK, and AGE-RAGE were related to PCOS and treatment.

CONCLUSIONS

CDD can effectively improve the symptoms of PCOS, and our network pharmacological analysis lays the foundation for future clinical research.

摘要

背景

多囊卵巢综合征(PCOS)是最常见的女性内分泌疾病。苍附导痰汤(CDD)可有效缓解PCOS患者的临床症状。

方法

为探究CDD治疗PCOS的活性成分及相关通路,进行了基于网络药理学的分析。从中药系统药理学分析平台获取CDD的活性成分及其潜在靶点。将从OMIM和GeneCards获得的PCOS相关基因导入STRING以建立蛋白质-蛋白质相互作用网络。最后,使用RStudio(Bioconductor)数据库进行基因本体(GO)分析和显著通路分析。

结果

从CDD中的1433种成分中共获得111种活性化合物,与118个蛋白质靶点相关。此外,发现736个基因与PCOS密切相关,其中44个与CDD重叠,因此被认为具有治疗相关性。通路富集分析确定了糖尿病并发症中的晚期糖基化终末产物受体(AGE-RAGE)信号通路、内分泌抵抗、白细胞介素-17信号通路、催乳素信号通路和缺氧诱导因子-1(HIF-1)信号通路。此外,磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-Akt)、胰岛素抵抗、Toll样受体、丝裂原活化蛋白激酶(MAPK)和AGE-RAGE与PCOS及治疗相关。

结论

CDD可有效改善PCOS症状,我们的网络药理学分析为未来临床研究奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/173c9fe230f1/ECAM2020-4086864.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/f10f9d4517a3/ECAM2020-4086864.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/4722b7fef9e3/ECAM2020-4086864.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/73406f32faca/ECAM2020-4086864.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/6f6ae726d564/ECAM2020-4086864.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/8485a6b71dc7/ECAM2020-4086864.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/5479b64c7f59/ECAM2020-4086864.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/cf36e0a66064/ECAM2020-4086864.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/bf750e2ec02c/ECAM2020-4086864.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/173c9fe230f1/ECAM2020-4086864.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/f10f9d4517a3/ECAM2020-4086864.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/4722b7fef9e3/ECAM2020-4086864.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/73406f32faca/ECAM2020-4086864.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/6f6ae726d564/ECAM2020-4086864.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/8485a6b71dc7/ECAM2020-4086864.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/5479b64c7f59/ECAM2020-4086864.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/cf36e0a66064/ECAM2020-4086864.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/bf750e2ec02c/ECAM2020-4086864.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3f/7057008/173c9fe230f1/ECAM2020-4086864.009.jpg

相似文献

1
Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.基于网络药理学的苍附导痰汤治疗多囊卵巢综合征有效成分及关键通路的研究
Evid Based Complement Alternat Med. 2020 Feb 21;2020:4086864. doi: 10.1155/2020/4086864. eCollection 2020.
2
The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway.苍附导痰汤对啮齿动物模型多囊卵巢综合征的改善作用与m6A甲基化和Wnt/β-连环蛋白通路有关。
Gynecol Endocrinol. 2023 Dec;39(1):2181637. doi: 10.1080/09513590.2023.2181637. Epub 2023 Feb 23.
3
A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome.基于网络药理学方法探究二仙汤治疗多囊卵巢综合征的作用机制
Chin Med. 2018 Aug 29;13:46. doi: 10.1186/s13020-018-0201-1. eCollection 2018.
4
Efficacy and safety of cangfu daotan decoction as an adjuvant treatment of Diane-35 for polycystic ovary syndrome: A systematic review and meta-analysis.苍附导痰汤辅助达英-35治疗多囊卵巢综合征的疗效与安全性:一项系统评价和Meta分析
Heliyon. 2024 Aug 28;10(17):e36959. doi: 10.1016/j.heliyon.2024.e36959. eCollection 2024 Sep 15.
5
Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Franchin Polycystic Ovary Syndrome.基于网络药理学的预测 Franchin 多囊卵巢综合征活性成分及潜在靶点的策略
Evid Based Complement Alternat Med. 2021 Aug 18;2021:6651307. doi: 10.1155/2021/6651307. eCollection 2021.
6
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.综合生物信息学和网络药理学探讨百灵胶囊治疗多囊卵巢综合征的作用靶点及分子机制。
BMC Complement Med Ther. 2023 Dec 15;23(1):458. doi: 10.1186/s12906-023-04280-6.
7
Effects of Cangfu Daotan Decoction on obese polycystic ovary syndrome and its mechanism.苍附导痰汤对肥胖型多囊卵巢综合征的作用及其机制。
Steroids. 2021 Jan;165:108740. doi: 10.1016/j.steroids.2020.108740. Epub 2020 Oct 31.
8
Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome.苍附导痰汤联合屈螺酮炔雌醇片(Ⅱ)治疗多囊卵巢综合征患者的疗效分析
Prostaglandins Other Lipid Mediat. 2024 Feb;170:106801. doi: 10.1016/j.prostaglandins.2023.106801. Epub 2023 Nov 18.
9
Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.网络药理学结合实验验证揭示和欢饮汤治疗多囊卵巢综合征伴胰岛素抵抗的作用机制。
J Ethnopharmacol. 2022 May 10;289:115057. doi: 10.1016/j.jep.2022.115057. Epub 2022 Feb 1.
10
Exploring the molecular targets and mechanism of in treating polycystic ovary syndrome based on network pharmacology.基于网络药理学探索[具体药物名称未给出]治疗多囊卵巢综合征的分子靶点及机制。
Ann Transl Med. 2023 Feb 15;11(3):149. doi: 10.21037/atm-23-29.

引用本文的文献

1
Mechanisms of c-Fos regulation of mTOR signaling via ERα/β in abnormal lipid metabolism of granulosa cells in PCOS.多囊卵巢综合征中颗粒细胞脂质代谢异常时c-Fos通过雌激素受体α/β调节mTOR信号通路的机制
Front Endocrinol (Lausanne). 2025 Aug 27;16:1587595. doi: 10.3389/fendo.2025.1587595. eCollection 2025.
2
Mechanistic insights into the Bushen Huatan Huoxue Formula and its components in ameliorating obesity-associated polycystic ovary syndrome.补肾化痰活血方及其成分改善肥胖相关性多囊卵巢综合征的机制研究
Chin Med. 2025 Jul 1;20(1):99. doi: 10.1186/s13020-025-01165-3.
3
Predicting the bioactive compounds of and elucidating its interaction with genes associated to obesity through network pharmacology and cell-based assay.

本文引用的文献

1
Study on Hypoglycemic Effect of the Drug Pair of Astragalus Radix and Dioscoreae Rhizoma in T2DM Rats by Network Pharmacology and Metabonomics.基于网络药理学和代谢组学的方法研究黄芪-山药药对治疗 2 型糖尿病大鼠的降血糖作用。
Molecules. 2019 Nov 8;24(22):4050. doi: 10.3390/molecules24224050.
2
Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology.基于 LPS 诱导的 BV2 细胞的网络药理学研究不同比例比例乳香酸与没药三萜烯配伍对神经炎症的保护作用及机制
Molecules. 2019 Oct 31;24(21):3946. doi: 10.3390/molecules24213946.
3
通过网络药理学和细胞实验预测其生物活性化合物,并阐明其与肥胖相关基因的相互作用。
Heliyon. 2024 Mar 5;10(5):e27363. doi: 10.1016/j.heliyon.2024.e27363. eCollection 2024 Mar 15.
4
Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis.苍附导痰丸通过破坏 PKP3/ERCC1/MAPK 轴缓解痰湿型多囊卵巢综合征。
J Ovarian Res. 2023 Jul 7;16(1):134. doi: 10.1186/s13048-023-01200-7.
5
Exploring potential pharmacological mechanisms of Decoction in the treatment of allergic rhinitis utilizing network pharmacology prediction and molecular docking-based strategies: experimental research.运用基于网络药理学预测和分子对接的策略探索该方剂治疗变应性鼻炎的潜在药理机制:实验研究
Ann Med Surg (Lond). 2023 May 15;85(6):2662-2676. doi: 10.1097/MS9.0000000000000804. eCollection 2023 Jun.
6
Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism.中医药对多囊卵巢综合征的作用及其细胞内分泌机制。
Front Endocrinol (Lausanne). 2023 May 16;14:956772. doi: 10.3389/fendo.2023.956772. eCollection 2023.
7
Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome.苍附导痰汤抑制多囊卵巢综合征大鼠颗粒细胞线粒体依赖性细胞凋亡。
Front Endocrinol (Lausanne). 2022 Nov 9;13:962154. doi: 10.3389/fendo.2022.962154. eCollection 2022.
8
Impact of Chinese Herbal Medicine on Glucolipid Metabolic Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.中药对多囊卵巢综合征女性糖脂代谢结局的影响:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2022 Sep 30;2022:3245663. doi: 10.1155/2022/3245663. eCollection 2022.
9
Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K/AKT/mTOR pathway.利多卡因通过PI3K/AKT/mTOR途径调节卵巢颗粒细胞生理功能对多囊卵巢综合征的保护作用。
Cytotechnology. 2022 Apr;74(2):283-292. doi: 10.1007/s10616-022-00528-0. Epub 2022 Feb 24.
10
Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.基于网络药理学研究菟丝子-丹参治疗多囊卵巢综合征(PCOS)的作用机制及实验验证。
J Ovarian Res. 2022 Apr 4;15(1):40. doi: 10.1186/s13048-022-00964-8.
Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
二甲双胍和二甲双胍联合吡格列酮治疗多囊卵巢综合征患者血清 IL-6 和 IL-8 水平的随机临床试验。
Horm Metab Res. 2019 Nov;51(11):714-722. doi: 10.1055/a-1018-9606. Epub 2019 Nov 4.
4
Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.改善姜黄素口服全身生物利用度的药物策略及其临床应用。
J Control Release. 2019 Dec 28;316:359-380. doi: 10.1016/j.jconrel.2019.10.053. Epub 2019 Nov 2.
5
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.一线诱导排卵治疗多囊卵巢综合征:一项个体参与者数据荟萃分析。
Hum Reprod Update. 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029.
6
Elucidation of the Mechanisms and Molecular Targets of Yiqi Shexue Formula for Treatment of Primary Immune Thrombocytopenia Based on Network Pharmacology.基于网络药理学阐明益气摄血方治疗原发性免疫性血小板减少症的作用机制及分子靶点
Front Pharmacol. 2019 Oct 1;10:1136. doi: 10.3389/fphar.2019.01136. eCollection 2019.
7
Exploring Pharmacological Mechanisms of Xiang Ju Tablets in the Treatment of Allergic Rhinitis via a Network Pharmacology Approach.基于网络药理学方法探索香菊片治疗变应性鼻炎的药理机制
Evid Based Complement Alternat Med. 2019 Sep 12;2019:6272073. doi: 10.1155/2019/6272073. eCollection 2019.
8
Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice.间充质干细胞通过抑制小鼠炎症来缓解脱氢表雄酮诱导的多囊卵巢综合征(PCOS)
Stem Cells Int. 2019 Sep 12;2019:9782373. doi: 10.1155/2019/9782373. eCollection 2019.
9
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.治疗慢性前列腺炎/慢性盆腔疼痛综合征的药物干预措施。
Cochrane Database Syst Rev. 2019 Oct 6;10(10):CD012552. doi: 10.1002/14651858.CD012552.pub2.
10
Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis.苍附导痰汤治疗多囊卵巢综合征:一项系统评价与Meta分析方案
Medicine (Baltimore). 2019 Sep;98(39):e17321. doi: 10.1097/MD.0000000000017321.